redefinindo INFARTO AGUDO DO MIOCARDIO

Recent clinical trials results combined with registry data demonstrate the safety and efficacy of the use of drug-eluting stents (DES) in patients with acute myocardial infarction (AMI) at least at one year. But beyond one year, will ongoing evaluation confirm these findings? What are the barriers to managing patients with DES? When should bare metal stents be utilized? How can we reduce stent thrombosis without increasing bleeding? Join our panel of experts, Drs Stone, White, and Harrington as they discuss major new clinical trial evidence on the optimal management of patients with AMI